Needham & Company LLC Reaffirms “Buy” Rating for Alphatec (NASDAQ:ATEC)
Needham & Company LLC reaffirmed their buy rating on shares of Alphatec (NASDAQ:ATEC – Free Report) in a report published on Friday morning,Benzinga reports. They currently have a $16.00 price objective on the medical technology company’s stock. Other equities research analysts have also recently issued reports about the stock. Barclays boosted their price target on […]
Needham & Company LLC reaffirmed their buy rating on shares of Alphatec (NASDAQ:ATEC – Free Report) in a report published on Friday morning,Benzinga reports. They currently have a $16.00 price objective on the medical technology company’s stock. Other equities research analysts have also recently issued reports about the stock. Barclays boosted their price target on […]
